Cargando…
MiR-139-5p negatively regulates PMP22 to repress cell proliferation by targeting the NF-κB signaling pathway in gastric cancer
Gastric cancer (GC) is one of the most common malignant tumors worldwide. Peripheral myelin protein 22 (PMP22) is a 22-kDa tetraspan glycoprotein that is predominantly expressed by myelinating Schwann cells. However, recent studies have shown that PMP22 is closely related to cell proliferation and t...
Autores principales: | Hou, Jingjing, Zhuo, Huiqin, Chen, Xin, Cheng, Jia, Zheng, Wei, Zhong, Mengya, Cai, Jianchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053325/ https://www.ncbi.nlm.nih.gov/pubmed/32174796 http://dx.doi.org/10.7150/ijbs.40338 |
Ejemplares similares
-
Inhibition of protein PMP22 enhances etoposide-induced cell apoptosis by p53 signaling pathway in Gastric Cancer
por: Hou, Jingjing, et al.
Publicado: (2021) -
RUNX represses Pmp22 to drive neurofibromagenesis
por: Hall, Ashley, et al.
Publicado: (2019) -
The Functional Role of PMP22 Gene in the Proliferation and Invasion of Osteosarcoma
por: Liu, Shuyong, et al.
Publicado: (2015) -
miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22
por: Li, Xiaodong, et al.
Publicado: (2017) -
miR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22
por: Lee, Ji-Su, et al.
Publicado: (2019)